Net Cash Provided by (Used in) Financing Activities in USD of Pasithea Therapeutics Corp. from Q1 2021 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Pasithea Therapeutics Corp. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2021 to Q1 2025.
  • Pasithea Therapeutics Corp. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $1.47M.
  • Pasithea Therapeutics Corp. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$3.21M, a 106% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

Pasithea Therapeutics Corp. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $1.47M Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-15
Q1 2023 $264K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2021 $1.21M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16

Pasithea Therapeutics Corp. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$3.21M -$59.1M -106% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-30
2021 $55.9M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.